妊娠期糖尿病并发子痫前期相关lncRNA的研究进展

蔡苗 苗1, 宋志 慧2, 宋丹 丹1, 柴金 杰1, 姚春 凤3, 郑婷 华2
1.华北理工大学 河北唐山 063000；2.唐山市妇幼保健院 河北唐山 063000；3.唐山工人医院 河北唐山 063000

摘要

摘要：妊娠期糖尿病和子痫前期均为妊娠期特有的疾病，容易导致多种不良妊娠结局的发生，因此其诊断和尽早干预对避免不良妊娠结局很重要。长链非编码RNA(LncRNA)是一类不编码蛋白的RNA，但其在基因表达调控方面发挥重要作用，妊娠期糖尿病和子痫前期的发病机制尚无定论，本文对各种lncRNA分型在妊娠期糖尿病和子痫前期孕妇胎盘组织中的差异表达及调控机制进行分析，协助从基因层面了解其对疾病的发生发展的影响。

关键词

关键词：娠期糖尿病；子痫前期；lncRNA；基因表达

参考

[1]Filardi T, Catanzaro G, Mardente S, et al. Non-coding RNA: role in gestational diabetes pathophysiology and complications[J]. International Journal of Molecular Sciences, 2020, 21(11): 4020.[2]Plows J F, Stanley J L, Baker P N, et al. The pathophysiology of gestational diabetes mellitus[J]. International journal of molecular sciences, 2018, 19(11): 3342.[3]Bridges M C, Daulagala A C, Kourtidis A. LNCcation: lncRNA localization and function[J]. Journal of Cell Biology, 2021, 220(2): e202009045.[4]Tan Y T, Lin J F, Li T, et al. LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer[J]. Cancer Communications, 2021,41(2): 109-120.[5]Schmitz S U, Grote P, Herrmann B G. Mechanisms of long noncoding RNA function in development and disease[J]. Cellular and molecular life sciences, 2016, 73: 2491-2509.[6]Juan J, Yang H. Prevalence, prevention, and lifestyle intervention of gestational diabetes mellitus in China[J]. International Journal of Environmental Research and Public Health, 2020, 17(24): 9517.[7]Hao L, Wu W, Xu Y, et al. LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer[J]. Molecules, 2023, 28(5): 2126.[8]Zhang Y, Qu L, Ni H, et al. Expression and function of lncRNA MALAT1 in gestational diabetes mellitus[J]. Adv Clin Exp Med, 2020, 29(8): 903-910.[9]Zhang Y, Wu H, Wang F, et al. Long non‐coding RNA MALAT 1 expression in patients with gestational diabetes mellitus[J]. International Journal of Gynecology & Obstetrics, 2018, 140(2): 164-169.[10]Ghafouri-Fard S, Dashti S, Taheri M. The HOTTIP (HOXA transcript at the distal tip) lncRNA: Review of oncogenic roles in human[J]. Biomedicine & Pharmacotherapy, 2020, 127: 110158.[11]Sun Y, Liu Y X. LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway[J]. European Review for Medical & Pharmacological Sciences, 2018, 22(10).[12]Cao Q, Zhang X, Xie F, Li Y, Lin F.Long-noncoding RNA HOXA transcript at the distal tip ameliorates the insulin resistance and hepatic gluconeogenesis in mice with gestational diabetes mellitus via the microRNA-423-5p/wingless-type MMTV integration site family member 7A axis[J]. Bioengineered, 2022, 13(5): 13224-13237.[13]Phipps E A, Thadhani R, Benzing T, et al. Pre-eclampsia: pathogenesis, novel diagnostics and therapies[J]. Nature Reviews Nephrology, 2019, 15(5): 275-289.[14]Rana S, Lemoine E, Granger J P, et al. Preeclampsia: pathophysiology, challenges, and perspectives[J]. Circulation research, 2019, 124(7): 1094-1112.[15]Brosens I, Puttemans P, Benagiano G. Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes[J]. American journal of obstetrics and gynecology, 2019, 221(5): 437-456.[16]Ghafouri-Fard S, Esmaeili M, Taheri M. H19 lncRNA: roles in tumorigenesis[J]. Biomedicine & Pharmacotherapy, 2020, 123: 109774.[17]Xu J, Xia Y, Zhang H, Guo H, Feng K, Zhang C. Overexpression of long non-coding RNA H19 promotes invasion and autophagy via the PI3K/AKT/mTOR pathways in trophoblast cells. Biomed Pharmacother. 2018;101:691-697.[18]Lu L, Hou Z, Li L, et al. Methylation pattern of H19 exon 1 is closely related to preeclampsia and trophoblast abnormalities. Int J Mol Med. 2014;34(3):765-771.[19]Xu F, Huang M, Chen Q, et al. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway. Cancer Res. 2021;81(22):5678-5691.[20]张静,徐琳,叶元华.晚发型重度子痫前期胎盘组织 LncRNA HIF1A-AS1、HIF1A 表达与胎盘螺旋动脉重铸的关系[J].中国生育健康杂志,2023,34(01):51-55.[21]霍春霞,谢玲,张爱萍.青海地区子痫前期孕妇lncRNA HIF1A-AS1 的表达及临床意义[J].中国优生与遗传杂志,2023,31(10):2171-2174.[22]Östlund I, Haglund B, Hanson U. Gestational diabetes and preeclampsia[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2004, 113(1): 12-16.[23]Wiznitzer A, Mayer A, Novack V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study[J]. American journal of obstetrics and gynecology, 2009, 201(5): 482. e1-482. e8.[24]高永妹.诱发妊娠期糖尿病孕妇发生子痫前期的风险因素探讨及其对妊娠结局的影响[J].中国妇幼保健，2016，31(23):4980-4982.[25]Jin WY, Lin SL, Hou RL, et al. Associations between maternal lipid profile and pregnancy complicatisons and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth. 2016;16:60.[26]Chen ES, Mazzotti DR, Furuya TK, et al. Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity. Clin Exp Med. 2009;9(4):319-325.